144 related articles for article (PubMed ID: 19027602)
21. Basilar artery remodelling in the genetically hypertensive rat: effects of nitric oxide synthase inhibition and treatment with valsartan and enalapril.
Ledingham JM; Laverty R
Clin Exp Pharmacol Physiol; 2000 Aug; 27(8):642-6. PubMed ID: 10901398
[TBL] [Abstract][Full Text] [Related]
22. Valsartan therapy in heart failure after myocardial infarction: the role of endothelial dependent vasorelaxation.
Thai H; Guarraia D; Johnson N; Goldman S; Gaballa MA
J Cardiovasc Pharmacol; 2007 Dec; 50(6):703-7. PubMed ID: 18091589
[TBL] [Abstract][Full Text] [Related]
23. Effects of perindopril and valsartan on expression of transforming growth factor-beta-Smads in experimental hepatic fibrosis in rats.
Xu W; Song S; Huang Y; Gong Z
J Gastroenterol Hepatol; 2006 Aug; 21(8):1250-6. PubMed ID: 16872305
[TBL] [Abstract][Full Text] [Related]
24. Myocardial vasoactive intestinal peptide and fibrosis induced by nitric oxide synthase inhibition in the rat.
Ye VZ; Hodge G; Yong JL; Duggan KA
Acta Physiol Scand; 2003 Dec; 179(4):353-60. PubMed ID: 14656372
[TBL] [Abstract][Full Text] [Related]
25. Cardioprotective effect of angiotensin II type 1 receptor antagonist associated with bradykinin-endothelial nitric oxide synthase and oxidative stress in Dahl salt-sensitive hypertensive rats.
Yoshida K; Kobayashi N; Ohno T; Fukushima H; Matsuoka H
J Hypertens; 2007 Aug; 25(8):1633-42. PubMed ID: 17620960
[TBL] [Abstract][Full Text] [Related]
26. Nitric oxide modulates air embolism-induced lung injury in rats with normotension and hypertension.
Liu YC; Kao SJ; Chuang IC; Chen HI
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1173-80. PubMed ID: 17880373
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of endothelial nitric oxide synthase induces and enhances myocardial fibrosis.
Kazakov A; Hall R; Jagoda P; Bachelier K; Müller-Best P; Semenov A; Lammert F; Böhm M; Laufs U
Cardiovasc Res; 2013 Nov; 100(2):211-21. PubMed ID: 23863197
[TBL] [Abstract][Full Text] [Related]
28. Apoptosis, coronary arterial remodeling, and myocardial infarction after nitric oxide inhibition in SHR.
Ono Y; Ono H; Matsuoka H; Fujimori T; Frohlich ED
Hypertension; 1999 Oct; 34(4 Pt 1):609-16. PubMed ID: 10523335
[TBL] [Abstract][Full Text] [Related]
29. Effects of nitric oxide synthase inhibition and low-salt diet on blood pressure and mesenteric resistance artery remodelling in genetically hypertensive rats.
Ledingham JM; Laverty R
Clin Exp Pharmacol Physiol; 2001 Sep; 28(9):761-3. PubMed ID: 11560124
[TBL] [Abstract][Full Text] [Related]
30. Effect of valsartan on the pathological progression of hepatic fibrosis in rats with type 2 diabetes.
Qiang G; Zhang L; Yang X; Xuan Q; Shi L; Zhang H; Chen B; Li X; Zu M; Zhou D; Guo J; Yang H; Du G
Eur J Pharmacol; 2012 Jun; 685(1-3):156-64. PubMed ID: 22546234
[TBL] [Abstract][Full Text] [Related]
31. Contribution of different Nox homologues to cardiac remodeling in two-kidney two-clip renovascular hypertensive rats: effect of valsartan.
Wang P; Tang F; Li R; Zhang H; Chen S; Liu P; Huang H
Pharmacol Res; 2007 May; 55(5):408-17. PubMed ID: 17324585
[TBL] [Abstract][Full Text] [Related]
32. Blood pressure variability, impaired autonomic function and vascular senescence in aged spontaneously hypertensive rats are ameliorated by angiotensin blockade.
Sueta D; Koibuchi N; Hasegawa Y; Toyama K; Uekawa K; Katayama T; Ma M; Nakagawa T; Waki H; Maeda M; Ogawa H; Kim-Mitsuyama S
Atherosclerosis; 2014 Sep; 236(1):101-7. PubMed ID: 25016364
[TBL] [Abstract][Full Text] [Related]
33. Combination of low-dose valsartan and enalapril improves endothelial dysfunction and coronary reserve in Nomega-nitro-L-arginine methyl ester-treated spontaneously hypertensive rats.
de Gasparo M; Hess P; Clozel M; Persohn E; Roman D; Germann PG; Clozel JP; Webb RL
J Cardiovasc Pharmacol; 2002 Nov; 40(5):789-800. PubMed ID: 12409988
[TBL] [Abstract][Full Text] [Related]
34. Tanshinone II-A attenuates cardiac fibrosis and modulates collagen metabolism in rats with renovascular hypertension.
Fang J; Xu SW; Wang P; Tang FT; Zhou SG; Gao J; Chen JW; Huang HQ; Liu PQ
Phytomedicine; 2010 Dec; 18(1):58-64. PubMed ID: 20638255
[TBL] [Abstract][Full Text] [Related]
35. Dietary nitrite supplementation attenuates cardiac remodeling in l-NAME-induced hypertensive rats.
Sonoda K; Ohtake K; Uchida H; Ito J; Uchida M; Natsume H; Tamada H; Kobayashi J
Nitric Oxide; 2017 Jul; 67():1-9. PubMed ID: 28438687
[TBL] [Abstract][Full Text] [Related]
36. Role of angiotensin II type 2 receptor during regression of cardiac hypertrophy in spontaneously hypertensive rats.
Der Sarkissian S; Tea BS; Touyz RM; deBlois D; Hale TM
J Am Soc Hypertens; 2013; 7(2):118-27. PubMed ID: 23414835
[TBL] [Abstract][Full Text] [Related]
37. Reversal of interstitial fibroblast hyperplasia via apoptosis in hypertensive rat heart with valsartan or enalapril.
Der Sarkissian S; Marchand EL; Duguay D; Hamet P; deBlois D
Cardiovasc Res; 2003 Mar; 57(3):775-83. PubMed ID: 12618239
[TBL] [Abstract][Full Text] [Related]
38. Melatonin prevents fibrosis but not hypertrophy development in the left ventricle of NG-nitro-L-arginine-methyl ester hypertensive rats.
Paulis L; Pechanova O; Zicha J; Krajcirovicova K; Barta A; Pelouch V; Adamcova M; Simko F
J Hypertens Suppl; 2009 Aug; 27(6):S11-6. PubMed ID: 19633445
[TBL] [Abstract][Full Text] [Related]
39. Effects of combination of angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist on inflammatory cellular infiltration and myocardial interstitial fibrosis after acute myocardial infarction.
Yu CM; Tipoe GL; Wing-Hon Lai K; Lau CP
J Am Coll Cardiol; 2001 Oct; 38(4):1207-15. PubMed ID: 11583905
[TBL] [Abstract][Full Text] [Related]
40. Combination therapy with telmisartan and spironolactone alleviates L-NAME exacerbated nephrosclerosis with an increase in PPAR-gamma and decrease in TGF-beta(1).
Takahashi T; Ono H; Ono Y; Ishimitsu T; Matsuoka H
Int Heart J; 2007 Sep; 48(5):637-47. PubMed ID: 17998773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
